Skip to content
Screener

Current ratio at other companies

Illumina logo
IlluminaILMN
1.8×0.0×
Quanterix Corporation logo
Quanterix CorporationQTRX
3.4×-3.3×
Revvity logo
RevvityRVTY
1.8×-1.5×
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
2.7×-1.8×
Agilent Technologies logo
Agilent TechnologiesA
2.1×0.0×
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
2.5×-1.1×

Other financials

Income statement

See full
Revenue$39.0M-1.9%
Gross profit$12.6M-13.9%
Operating income-$44.6M+0.5%
Net income-$44.7M-6.7%
EPS (diluted)-$0.140.0%

Balance sheet

See full
Cash & equivalents$62.6M+10.5%
Total debt$61.8M+17.1%
Total equity-$33.2M-154%
Total assets$751.9M-8.9%

Cash flow

See full
Operating cash flow-$35.6M-21.1%
CapEx$1.6M+183%
Free cash flow-$37.1M-24.1%

Valuation

See full
Market cap$368.06M-5.6%
Enterprise value$367.25M-4.8%
P/S2.3×-0.2×

Profitability

See full
Gross margin36.4%+15.0pp
Operating margin-83.5%-37.4pp
Net margin-82.5%-35.5pp
FCF margin-77.5%-13.2pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×

Where this comes from

Calculated from Pacific Biosciences of California’s reported figures.

Based on the most recent quarter.

The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 5:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001299130-26-000122

FAQ

What is Pacific Biosciences of California's current ratio?
Pacific Biosciences of California (PACB) reported current ratio of 4.9× in Q2 2026.
How has Pacific Biosciences of California's current ratio changed year-over-year?
Pacific Biosciences of California's current ratio decreased by 28.9% year-over-year, from 6.9× to 4.9×.
What is the long-term trend for Pacific Biosciences of California's current ratio?
Over 5 years (2020 to 2025), Pacific Biosciences of California's current ratio has grown at a -11.0% compound annual growth rate (CAGR), from 9.2× to 5.1×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about Pacific Biosciences of California's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude